Zeo ScientifiX (ZEOX) Enterprise Value (2013 - 2026)
Zeo ScientifiX (ZEOX) posted quarterly Enterprise Value of -$1.8 million for Q2 2026, down 240.59% year-over-year from $1.3 million in Q2 2025, and down 79.22% quarter-over-quarter from -$1.0 million in Q1 2026.
Zeo ScientifiX (ZEOX) Enterprise Value (2013 - 2026) Analysis & Trends
Zeo ScientifiX's Enterprise Value history runs 14 years deep, the most recent figure standing at -$1.8 million for Q2 2026.
- In Q2 2026, Enterprise Value fell 240.59% year-over-year to -$1.8 million; the TTM figure through Apr 2026 stood at -$1.8 million (down 240.59% YoY), while the FY2025 annual figure was -$221000.0, up 66.36% from the prior year.
- Enterprise Value for Q2 2026 stood at -$1.8 million, down from -$1.0 million in the prior quarter.
- The five-year high for Enterprise Value was -$66002.0 in Q2 2022, with the low at -$3.8 million in Q4 2022.
- The 5-year median for Enterprise Value is -$733000.0 (2024), against an average of -$959721.5.
- The sharpest annual moves came in 2022 and 2025: Enterprise Value sank 3356.76% in 2022, then surged 77.38% in 2025.
- Zeo ScientifiX's Enterprise Value stood at -$3.8 million in 2022, then surged by 53.21% to -$1.8 million in 2023, then soared by 62.59% to -$657000.0 in 2024, then soared by 66.36% to -$221000.0 in 2025, then tumbled by 735.29% to -$1.8 million in 2026.
- Business Quant data shows ZEOX's Enterprise Value at -$1.8 million in Q2 2026, -$1.0 million in Q1 2026, and -$221000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -3.31 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.16 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 2.12 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -18.39 Bn |
| 10 | Zeo ScientifiX | 11.02 Mn | 9.17 Mn | 2.06 Mn | -1.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -1.85 Mn |
| Jan 31, 2026 | -1.03 Mn |
| Oct 31, 2025 | -221,000.00 |
| Jul 31, 2025 | -250,000.00 |
| Apr 30, 2025 | -542,000.00 |
| Jan 31, 2025 | -720,000.00 |
| Oct 31, 2024 | -657,000.00 |
| Jul 31, 2024 | -1.11 Mn |
| Apr 30, 2024 | -746,000.00 |
| Jan 31, 2024 | -1.17 Mn |
| Oct 31, 2023 | -1.76 Mn |
| Jul 31, 2023 | -633,000.00 |
| Apr 30, 2023 | -1.13 Mn |
| Jan 31, 2023 | -1.42 Mn |
| Oct 31, 2022 | -3.75 Mn |
| Jul 31, 2022 | -74,665.00 |
| Apr 30, 2022 | -66,002.00 |
| Jan 31, 2022 | -150,320.00 |
| Oct 31, 2021 | -108,570.00 |
| Jul 31, 2021 | -29,207.00 |